AstraZeneca (AstraZeneca) Interest Expense : $-1,596 Mil (TTM As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is AstraZeneca Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. AstraZeneca's interest expense for the three months ended in Dec. 2023 was $ -408 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-1,596 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. AstraZeneca's Operating Income for the three months ended in Dec. 2023 was $ 2,004 Mil. AstraZeneca's Interest Expense for the three months ended in Dec. 2023 was $ -408 Mil. AstraZeneca's Interest Coverage for the quarter that ended in Dec. 2023 was 4.91. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

AstraZeneca Interest Expense Historical Data

The historical data trend for AstraZeneca's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Interest Expense Chart

AstraZeneca Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-1,402.00

-1,272.00

-1,276.00

-1,330.00

-1,589.00

AstraZeneca Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-344.00	-365.00	-431.00	-392.00	-408.00

AstraZeneca Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1,596 Mil.

AstraZeneca (NAS:AZN) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

AstraZeneca's Interest Expense for the three months ended in Dec. 2023 was $-408 Mil. Its Operating Income for the three months ended in Dec. 2023 was $2,004 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $23,222 Mil.

AstraZeneca's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	2004	/	-408
	=	4.91

The higher the ratio, the stronger the company's financial strength is.

AstraZeneca (AstraZeneca) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:Sweden AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.